Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature With Predictive and Prognostic Value

Cancer Research - United States
doi 10.1158/0008-5472.can-15-3284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Prognostic Value of Kallikrein-Related Peptidase 12 (KLK12) mRNA Expression in Triple-Negative Breast Cancer Patients

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2020English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

The Prognostic Value of BRCA1 Promoter Methylation in Early Stage Triple Negative Breast Cancer

journal of Cancer Therapeutics and Research
2014English

Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy